ÐÏࡱá>þÿ <>þÿÿÿ;ÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿì¥Áaà ð¿¿bjbj[[ 4$9bE\9bE\¿ ÿÿÿÿÿÿ·h h àààààÿÿÿÿôôôô, ô)<<<<<<+++œ(ž(ž(ž(ž(ž(ž($Y+¶.`Â(à+++++Â(àà<<ï×(WWW+"à<à<œ(W+œ(WWŽ’%ø^'<ÿÿÿÿðwš2—ÑÿÿÿÿM Š&ˆ(í(0)š&Äo.Wo. ^'^'&o.à„'++W+++++Â(Â(W+++)++++ÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿo.+++++++++h > ¦: DRUG DISCOVERY AND DEVELOPMENT (MSc/PgDip/PgCert) 57B220B1/61B220VX/62B220VZ Duration: 12 months full-time (MSc); 9 months full-time or 18 months part-time (PgDip). Aim: To equip students for careers developing and expanding our current knowledge of drug discovery and development. To achieve this, the programme will provide a multi-disciplinary approach to the study of drug discovery and development; mechanisms of drug action; preclinical and clinical trials; and regulatory affairs. Content: The programme of taught courses will comprise lectures, tutorials, practical classes and demonstrations. The curriculum includes biochemical and molecular aspects of drug action; drug transport, metabolism and excretion; toxicology; pharmacokinetics; computing studies; industrial aspects of drug development; therapeutic drug monitoring; the influence of disease on drug handling; drug-drug interactions; the design and conduct of volunteer and clinical trials; monitoring drug safety and an understanding of drug regulation. In addition, the programme includes Bio-Business which aims to bring the ideas and concepts of the commercialisation of scientific ideas to the student. Candidates shall be required to attend the following designated programme of courses: Stage 1 MT5010 Basic Skills Induction (0 credit points) MT5003 Drug Metabolism and Toxicology (15 credit points) BT5013 Small Molecule Drug Discovery (15 credit points) BT5012 Introduction to Bio-Business and the Commercialisation of Bioscience Research (15 credit points) GS50M1 Generic Skills for Taught Postgraduate Students (0 credit points) MT5028 Basic Research Methods (15 credit points) Plus one of the following electives MB5022 Introduction to Molecular Biology (15 credit points) Or MT5024 Molecular Pharmacology (15credit points) Or PU5017 Applied Statistics (15 credit points) Stage 2 BT5508 Advanced Bio-Business and the Commercialisation of Bioscience Research (15 credit points) BT5509 Biologic Drug Discovery (15 credit points) MT5518 Pharmacokinetics (15 credit points) MT5515 Basic Research Methods (15 credit points) Above courses contribute to degree award. The following courses are available as additional optional credits MT5501 Pharmacovigilance (5 credit points) Stage 3 MT5903 Research Project (60 credit points) Assessment: By practical work, by written essays, written examinations and by oral presentations, or by a combination of these, as prescribed for each course. The project will be assessed on the basis of performance, written thesis, and oral presentation. There will usually be an oral examination to complete the programme. Candidates must pass all courses at an appropriate standard for the award of the MSc degree. 2MNW¨¬î ö ¢ ù ú  ! ' 1 2 3 O íÛíɵ¤��¤n\NN*CJOJQJ^JaJh¬NÈCJOJQJ^JaJ#hÿ(÷h½s¾>*CJOJQJ^JaJ hÿ(÷h9’CJOJQJ^JaJ hÿ(÷h–ãCJOJQJ^JaJ&hÿ(÷h–ã6�CJOJQJ]�^JaJ hÿ(÷hxìCJOJQJ^JaJ&hÿ(÷hxì6�CJOJQJ]�^JaJ#hÿ(÷h9’5�CJOJQJ^JaJ#hÿ(÷hxì5�CJOJQJ^JaJ#hÿ(÷h:;¨5�CJOJQJ^JaJ2MN§¨í î ¢ £ ù ú   3 l ¤ òåòòØËË˹¹ò¯¯¡“““ ÆSdð¤gdoA ÆSdð¤gdfÒ dð¤gd½s¾$ Æ0dð¤a$gd:;¨ $dð¤a$gd¤.Ð $dð¤a$gd–ã $dð¤a$gd:;¨ $dð¤a$gd:;¨O ] ` j l q r ˆ ’ “ • ˜ ¢ £ ¤ ª ± æ ú ý   !BFISTUX[†‡ˆïÞÐïÐÂÐïÂïÞÐÞï±ïÐï±ÞÐÞï ïÞÐÞ’…{…jX#hÿ(÷h½s¾6�CJOJQJ^JaJ hÿ(÷h¯L®CJOJQJ^JaJh¯L®CJOJQJhâe h¯L®CJOJQJh½s¾CJOJQJ^JaJ hÿ(÷hÚÞCJOJQJ^JaJ hÿ(÷h†2-CJOJQJ^JaJh€ ­CJOJQJ^JaJh¬NÈCJOJQJ^JaJ hÿ(÷h¬NÈCJOJQJ^JaJ hÿ(÷h½s¾CJOJQJ^JaJ" U†‡ˆ­éí MNVW¸êGµ¶áâñçñÕññññññññññññǶñññ Æ S„dð¤gdoA ÆSdð¤gd¬NÈ ÆS„Ðdð¤^„ÐgdoA Æ„gd¯L® ÆSdð¤gdoAˆ��­ÚÝçèéêíñóÿ >AKNW]}íÛɸ§™§™‡u¸d™¸§™§V‡™§™¸D¸™#hÿ(÷h½s¾>*CJOJQJ^JaJh½s¾CJOJQJ^JaJ hÿ(÷hß|cCJOJQJ^JaJ#h¬NÈh½s¾6�CJOJQJ^JaJ#h¬NÈh¬NÈ6�CJOJQJ^JaJh¬NÈCJOJQJ^JaJ hÿ(÷h¬NÈCJOJQJ^JaJ hÿ(÷h½s¾CJOJQJ^JaJ#hÿ(÷h½s¾6�CJOJQJ^JaJ"hZkðh½s¾5�6�OJQJ^JaJ#hÿ(÷hÚÞ6�CJOJQJ^JaJ}Š�©¬¶½¾¿ÖØÙÛÞèîð FG£¬µÒÕßâë ïáïÐáïÂï´ïÂïÐáï£ï£ïÐáï•ï…x…ïÐáïfïÐáï#hÿ(÷h½s¾>*CJOJQJ^JaJhKô6�CJOJQJaJhÿ(÷h½s¾6�CJOJQJaJhgQhCJOJQJ^JaJ hÿ(÷hOBCJOJQJ^JaJhÓ:¢CJOJQJ^JaJhS(•CJOJQJ^JaJ hÿ(÷h¬NÈCJOJQJ^JaJh¬NÈCJOJQJ^JaJ hÿ(÷h½s¾CJOJQJ^JaJ$âêë¹¾¿ñññàÑÑÀ$ Æ„d¤a$gd–ã Æ0dð¤gd¤.Ð$ Æ„d¤a$gd:;¨ ÆSdð¤gdoA"H^¸½¾¿íÜÈܷܨ—…#h:;¨hxì5�CJOJQJ^JaJ hÿ(÷h–ãCJOJQJ^JaJhÿ(÷h–ãCJOJQJaJ hÿ(÷hÝd4CJOJQJ^JaJ&hÿ(÷hxì6�CJOJQJ]�^JaJ hÿ(÷hxìCJOJQJ^JaJ#hÿ(÷h½s¾5�CJOJQJ^JaJ 21�h:p·5°‚. °ÆA!° "° #� $� %°°Ä°Ä �Ä s˜žžžžžžž666666666vvvvvvvvv666666>666666666666666666666666666¨6666666666¸666666666666hH66666666666666666666666666666666666666666666666666666666666666666°62ÀÐàð 0@P`p€�ÀÐàð2(Øè 0@P`p€�ÀÐàð 0@P`p€�ÀÐàð 0@P`p€�ÀÐàð 0@P`p€�ÀÐàð 0@P`p€�ÀÐàð 0@P`p€�8XøV~� °ÀЀàð 0@àð 0@àð 0@àð 0@àð 0@àð 0@àð 0@àð 0@àð 0@àð 0@àð 0@àð 0@àð 0@àð 0@ OJPJQJ_HmH nH sH tH J`ñÿJ 9’Normal d¤ÈCJ_HaJmH sH tH ^^ xì Heading 2$dð¤@&a$>*CJOJPJQJ^JaJDA òÿ¡D Default Paragraph FontRióÿ³R 0 Table Normalö4Ö l4Öaö (k ôÿÁ( 0No List @³ò@ 9’ List Paragraph ^„Ðm$R™R \0 Balloon Text dð¤CJOJQJ^JaJNþ/òÿN \0Balloon Text CharCJOJQJ^JaJPþ/òÿ!P xìHeading 2 Char>*CJOJPJQJ^JaJB' òÿ1B ¯L®0Comment ReferenceCJaJXBX ¯L®0 Comment Text$dð¤a$CJOJPJQJaJJþ/òÿQJ ¯L®0Comment Text CharOJPJQJtH \jAB\ eÇ0Comment Subject$d¤Èa$5�OJPJQJ\�Vþ/òÿqV eÇ0Comment Subject Char5�OJPJQJ\�tH PK!éÞ¿ÿ[Content_Types].xml¬‘ËNÃ0E÷Hüƒå-Jœ²@%é‚ÇŽÇ¢|ÀÈ™$ÉØ²§Uû÷LÒTB¨ l,Ù3÷ž;ãr½µÃ˜œ§J¯òB+$ëG]¥ß7OÙ­V‰�vn±¦B`2ǃäí,ú!"ºE3žp#9‹ÅG„úúQdÁµ°Á; HŒ xuvÏ Ü “™ �×ÂÈ0F[,±FášœK sOì“'3w ¡#ÛÜŠ�üvfSÐVbs„Ø y“¢X  ޱpä5vˆ±euw 1âz@† ãl,œ»Äi!b IŸ ŒjZí‘ò2·„|±9¸ã´µ­º��L$܈ZÈ÷15ÂxÍŠl.û(¢zÀ÷‘m${ód¨ã:\@¦'˜2§3œÛln$°^-é×@^ìi? óÈD&‚Ú|î#Ætd›!Ц6l�Ä¡ŽýˆB‰"ç&6ø3ïyy@ñÖtß!ØH÷éjp”U§´*ye–Xry3£~{s:FXI ¿¡ç‰O÷5Y÷ÿ[Y!}õíS˪.ª 7b½£öÖd|n]¼–ŒÈÅ×î6šÅ71Ü.› ì½t¿—n÷/ÝÛîçw/Ø+�ù–[Åt«®6îÑÖ}û˜PÚsŠ÷¹ÚºsèL£. J;õÌŠ³ç¸i‡òN† Ü$AÊÆI˜ø„ˆ°¢)ìï‹®t2á ×îL‡m¿¶ú–x:‹Ø(}\-å£i*‰ÕxÁÏÆáQC¤èJuõ–¹Wl'êQyI@Ú¾ m2“DÙB¢º”ARæ4 µ²w¢naQ“î—©Ú`Ô²¬ÀÖÉ� WÃõ=0#x¢B�džÒT/³«’ù.3½-˜FÀ>bY«L×%×­Ë“«KKí ™6Hhåf’P‘Q=Œ‡h„Õ)GÏBãms]_¥Ô 'C¡æƒÒZѨÖþ�Åys vëÚ@c])hì7ÜJÙ‡’¢iÃÃc?FS¨.·¼ˆNàÝÙP$é e™&\´Ó€+ÑIÕ "'%QÕËÏÒ@c¥!Š[±‚paÉÕAV.9Hº™d<ã¡ÐÓ®�ÈH§§ ð©VX¯*óóƒ¥%›Aº{áèØÐYr A‰ùÕ¢ àˆpxûSL£9"ð:3²Uý­5¦…ìêïU ¥ãˆNC´è(º˜§p%åu–Å@;[¬ª…dÑÙ`õ Ý4ë)‡­]÷t#9M4W=ÓPÙ5í*f̰lk±<_“×X-C š¦wøTº×%·¾Ôºµ}BÖ% àYü,]÷ A£¶šÌ &oʰÔìŨÙ;– <…ÚYš„¦ú•¥Ûµ¸e=Â: ž«óƒÝzÕÂÐx¹¯T‘Vß=ôOlpÄ£ /�gTp•Jøð� ØõÔž$• ¸Eî‹Å­GÎ,! ÷AÁozAÉr…šßÉye¯�«ùÍr®éûåbÇ/Ú­ÒCh,"ŒŠ~úÍ¥ ¯¢è|ñåE�o|}‰–oÛ. Y”gêëJ^W__Š¥í__¢ó RêÖËõV%W/7»9¯ÝªåêA¥•kW‚j»ÛüZ½ûÐuŽØk–¯Ò©å*Å Èy•‚¤_«çª^©ÔôªÍZÇk>\lc`å©|,báU¼vÿÿÿPK! Ñ�Ÿ¶'theme/theme/_rels/themeManager.xml.rels„�M Â0„÷‚wooÓº‘&݈ЭÔ„ä5 6?$Qìí ®,.‡a¾™i»—�Éc2Þ1hª:é•qšÁm¸ìŽ@RN‰Ù;d°`‚Žo7íg‘K(M&$R(.1˜r'J“œÐŠTù€®8£�Vä"£¦AÈ»ÐH÷u} ñ›|Å$½b{Õ–Pšÿ³ý8‰g/]þQAsÙ…(¢ÆÌà#›ªLÊ[ººÄßÿÿPK-!éÞ¿ÿ[Content_Types].xmlPK-!¥Ö§çÀ6 0_rels/.relsPK-!ky–ƒŠtheme/theme/themeManager.xmlPK-!ªR%߯‹Ötheme/theme/theme1.xmlPK-! Ñ�Ÿ¶'Ð theme/theme/_rels/themeManager.xml.relsPK]Ë ¿ $ÿÿÿÿO ˆ}¿  â¿ ðLð# ð †ÁÅÁ@ñÿÿÿ€€€÷ð’ðð0ð( ð ððB ðS ð¿Ëÿ ?ð$)*0Á Á NNmmqr’“T†��WW©¶··¸¸½¾¿ÖØÙÛèF£¬Òß  ¾ Á ãL>ºÚä�ÿÿÿÿÿÿÿÿÿIk²;ÆVš)ÿÿÿÿÿÿÿÿÿ5G¤B+ìÿÿÿÿÿÿÿÿÿ0¬j” šÿÿÿÿÿÿÿÿÿõsÃ}À‹ ›ÿÿÿÿÿÿÿÿÿ„Є˜þÆÐ^„Ð`„˜þOJQJ^Jo(" „ „˜þÆ ^„ `„˜þOJQJ^Jo( „p„˜þÆp^„p`„˜þ.„@ „˜þÆ@ ^„@ `„˜þ.„„˜þÆ^„`„˜þ.„à„˜þÆà^„à`„˜þ.„°„˜þư^„°`„˜þ.„€„˜þÆ€^„€`„˜þ.„P„˜þÆP^„P`„˜þ. „ „˜þ^„ `„˜þOJQJo(·ð€„p„˜þ^„p`„˜þOJQJ^Jo(o€ „@ „˜þ^„@ `„˜þOJQJo(§ð€ „„˜þ^„`„˜þOJQJo(·ð€„à„˜þ^„à`„˜þOJQJ^Jo(o€ „°„˜þ^„°`„˜þOJQJo(§ð€ „€„˜þ^„€`„˜þOJQJo(·ð€„P„˜þ^„P`„˜þOJQJ^Jo(o€ „ „˜þ^„ `„˜þOJQJo(§ð„Є˜þÆÐ^„Ð`„˜þOJQJ^Jo(" #„ „˜þÆ ^„ `„˜þOJQJ^Jo( „p„˜þÆp^„p`„˜þ.„@ „˜þÆ@ ^„@ `„˜þ.„„˜þÆ^„`„˜þ.„à„˜þÆà^„à`„˜þ.„°„˜þư^„°`„˜þ.„€„˜þÆ€^„€`„˜þ.„P„˜þÆP^„P`„˜þ.„Є˜þ^„Ð`„˜þCJOJQJaJo(·ð€„ „˜þ^„ `„˜þOJQJ^Jo(o€ „p„˜þ^„p`„˜þOJQJo(§ð€ „@ „˜þ^„@ `„˜þOJQJo(·ð€„„˜þ^„`„˜þOJQJ^Jo(o€ „à„˜þ^„à`„˜þOJQJo(§ð€ „°„˜þ^„°`„˜þOJQJo(·ð€„€„˜þ^„€`„˜þOJQJ^Jo(o€ „P„˜þ^„P`„˜þOJQJo(§ð „Є˜þ^„Ð`„˜þOJQJo(·ð€„ „˜þ^„ `„˜þOJQJ^Jo(o€ „p„˜þ^„p`„˜þOJQJo(§ð€ „@ „˜þ^„@ `„˜þOJQJo(·ð€„„˜þ^„`„˜þOJQJ^Jo(o€ „à„˜þ^„à`„˜þOJQJo(§ð€ „°„˜þ^„°`„˜þOJQJo(·ð€„€„˜þ^„€`„˜þOJQJ^Jo(o€ „P„˜þ^„P`„˜þOJQJo(§ðãL> 5G¤B Ik²;0¬jõsÃ}ÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿbvtÂ܉x:á–,~VP$ÖÛP…$c@%âýZärfM<¹—         (N2Hndµ�J`TôÖÊúÚœ\þ¶à`n,þœ/ò¼.¬Î¤ÔV                 \ 4/Y_;å ÈB âO`/)†2- v3Ýd4·5<;oAOBôCJ²(P+X\�MaÓrcß|cgQh¶+iCmn³Bwo ß!‡Ý7’9’L“S(•Ó:¢MU¢›'¤:;¨€ ­¯L®u)³å)³°Qµ½s¾lÂeǬNÈÓQɤ.ÐfÒësÖ!\Ú«ÛÚÞ–ãópèxìEîZkðKôÿ(÷þ6ú cþ¿ Á ÿ@€¿ ˜@ÿÿUnknownÿÿÿÿÿÿÿÿÿÿÿÿ G�ÿ*àAxÀ ÿTimes New Roman5�€Symbol3.� ÿ*àCxÀ ÿArial7.�ÿáÿ¬@ ŸCalibriY� CG TimesTimes New Roman5.� ÿ.á[`À)ÿTahoma?=� ÿ*àCxÀ ÿCourier New;�€WingdingsA�ÿàÿ$BŸCambria Math"1ˆðÐhM{D§M{D§�ó'š% �š% !ð  ´´��0º º  3ƒQðüýHP ðÿ $Päÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿ9’2!xx  ÜÿÿMelanie McCann Mcdonald, Dee      þÿà…ŸòùOh«‘+'³Ù0|�˜¤°ÈÔè   , 8 D P\dltäMelanie McCann Normal.dotmMcdonald, Dee2Microsoft Office Word@@Ná]SnÍ@nÿ&—Ñ@nÿ&—Ñš% þÿÕÍÕœ.“—+,ù®DÕÍÕœ.“—+,ù®@ü hp�˜ ¨ °¸ÀÈ Ð ÝäºÚÁÏÍøº   TitleP <D_NewReviewCycleä þÿÿÿ !"#$%&'()*þÿÿÿ,-./012þÿÿÿ456789:þÿÿÿýÿÿÿ=þÿÿÿþÿÿÿþÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿRoot Entryÿÿÿÿÿÿÿÿ ÀFÐ^¦2—Ñ?€1Tableÿÿÿÿÿÿÿÿ�.WordDocumentÿÿÿÿÿÿÿÿ4$SummaryInformation(ÿÿÿÿ+DocumentSummaryInformation8ÿÿÿÿÿÿÿÿÿÿÿÿ3CompObjÿÿÿÿÿÿÿÿÿÿÿÿrÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿþÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿþÿ ÿÿÿÿ ÀF Microsoft Word 97-2003 Document MSWordDocWord.Document.8ô9²q